CC Chemours Co
Company Analysis
Latest News
🔴 Chemours is trading 5.2% down today after Morgan Stanley cut its target to $18
Chemours is trading at $14.93 (-5.21%) after Morgan Stanley reduced its price target to $18 from $21 while maintaining an Equalweight rating on August 10,...
🟢 Chemours is trading 6.68% up today amid recovery after August 5's 18.63% drop
Chemours is trading 6.68% up at $16.12, with the move appearing primarily recovery-oriented rather than tied to a confirmed fresh catalyst. - Shares fell...
Chemours Misses on Revenue and Earnings While Bleeding Red Ink — Can Cost Cuts and Debt Paydowns Outrun a Weakening Demand Cycle?
Shares of Chemours cratered nearly 10% after the specialty chemicals maker delivered a second quarter that fell short on virtually every line that matters to...
🟢 Chemours is trading 4.3% up today as materials-sector strength supports recovery
Chemours is trading at $15.21 (+4.25%) as materials-sector strength supports the recovery after its earnings-driven selloff. - August 5’s 18.63% decline...
🔴 Chemours is trading 11% down today after Q2 earnings miss and lowered Q3 guidance
Chemours is trading 11% down at $15.95 after reporting second-quarter 2026 results that missed analyst estimates for both revenue and earnings per share. •...
🔴 Chemours is trading 13% down today after missing Q2 estimates and issuing soft Q3 guidance
Chemours is trading 13% down at $15.60 after missing Q2 2026 revenue and EPS expectations and issuing soft Q3 guidance. • The company reported a large GAAP...
🔴 Chemours is trading 9.4% down today on soft Q3 guidance and refrigerant inventory headwinds
Chemours is trading 9.4% down at $16.25 following its Q2 2026 earnings report, which featured a revenue miss and cautious forward guidance. • Management...
🔴 Chemours is trading 10.1% down today after Q2 earnings miss and weak Q3 EBITDA outlook
Chemours is trading 10.1% down at $16.12 after missing Q2 2026 revenue and EPS expectations and issuing a soft outlook for the upcoming quarter. • The company...
🔴 Chemours is trading 9.8% down today after missing Q2 revenue and EPS expectations
Chemours is trading 9.8% down at $16.17 after reporting second-quarter 2026 results that missed revenue and EPS expectations. • While the company posted an...
Chemours' second quarter revenue misses estimates, but Adjusted EBITDA beats on pricing strength and APM growth.
The Chemours Company reported second quarter 2026 net sales of $1.59 billion, a 1% decrease year-over-year, missing analyst expectations. The company posted an...
🟢 Chemours is trading 4.0% up today ahead of its Q2 earnings report
Chemours is trading at $17.80 (+4.03%) as investors position ahead of its August 04, 2026, earnings report amid a broader rally in materials stocks. •...
Chemours Co Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Chemours Co is projected to report Q2 2026 revenue of $1.66 billion and earnings per share of $0.43, while the stock currently trades at $17.09 compared to an...
🔴 Chemours is trading 4.7% down today amid broader materials sector weakness
Chemours is trading 4.7% down today at $16.30 amid weakness in the broader materials sector and mixed overall market sentiment. • The move appears driven...
🟢 Chemours is trading 4.1% up today as risk sentiment improves following macro data
Chemours is trading at $17.93 (+4.1%) as risk sentiment improves following macro developments and durable goods data. • The stock is rebounding modestly after...
🔴 Chemours is trading 4.1% down today on profit-taking after recent gains
Chemours is trading at $17.49 (down 4.1%), reversing part of its sharp rally from earlier this week as traders lock in profits. • There are no new...
🔴 Chemours is trading 4.5% down today on potential profit-taking
Chemours is trading 4.5% down at $17.43 on potential profit-taking following recent gains earlier this week. • There are no fresh company-specific headlines,...
🟢 Chemours is trading 4.4% up today amid broader risk-on market sentiment
Chemours is trading 4.4% up at $17.94 as the stock participates in a broader risk-on market environment with major U.S. indices trading higher. • The move...
🔴 Chemours is trading 4.1% down today amid broader market weakness
Chemours is trading at $17.75 (-4.11%) amid broader market pressure and a lack of fresh company-specific catalysts. • The decline aligns with a softer trading...
🔴 Chemours Plunges 4.4% as NY Attorney General Sues Over PFAS Pollution
Chemours shares fell 4.4% to $17.57 after the New York Attorney General filed a lawsuit against the company, alongside 3M and DuPont, for contributing to...
🔴 CC extends move to 5.9% down
CC is trading at $18.94, down 5.9% versus the comparison close of $20.14 during regular trading. This is a price-movement alert; no separate company-specific...